HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 181-192 of 4,505
Drug study icon
Not Yet RecruitingNCT07396870

LY03020 for schizophrenia

What is this study about?

Researchers are comparing LY03020 and placebo to find out how the approaches affect psychotic symptoms in adults with schizophrenia.

This study isn't recruiting yet.

In Beijing
SchizophreniaMedication studyAges 18–65
Countries
China
Sponsor
Luye Pharma Group Ltd.
Drug study icon
Not Yet RecruitingNCT06649214

Olanzapine-Samidorphan Tablets in Adults With Schizophrenia

What is this study about?

Researchers are comparing Olanzapine-samidorphan; and Olanzapine to find out how the approaches affect body weight in adults with schizophrenia.

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaMedication studyAges 18–55
Countries
Sponsor
Qilu Pharmaceutical Co., Ltd.
Drug study icon
Not Yet RecruitingNCT05850585

Efficacy of Fecal Microbiota Transplantation(FMT) for schizophrenia

What is this study about?

Researchers are comparing Fecal microbiota transplantation(FMT) and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaMedication studyAges 18–65
Countries
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Behavioral study icon
Not Yet RecruitingNCT06971328

ACT-Based Psychoeducation for Schizophrenia Caregivers

Official study title

Effects of Acceptance and Commitment-Based (ACT) Psychoeducation on Caregiver Burden, Posttraumatic Growth and Psychological Resilience in Caregivers of Patients With Schizophrenia

This study isn't recruiting yet.

In Erzurum
SchizophreniaInterventional studyAges 18 months+
Countries
Türkiye
Sponsor
Ataturk University
Drug study icon
Not Yet RecruitingNCT03575000

Bromocriptine for people with Schizophrenia and Prediabetes

Official study title

Open-label, Flexible-dose Adjunctive Bromocriptine for Patients With Schizophrenia and Prediabetes

This study isn't recruiting yet.

In Pittsburgh
SchizophreniaMedication studyAges 18+
Countries
United States
Sponsor
VA Pittsburgh Healthcare System
Device study icon
Not Yet RecruitingNCT07369401

Deep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory Schizophrenia

Official study title

Efficacy and Safety of Deep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory Schizophrenia: A Prospective, Single-Center, Double-Blind, Randomized Controlled Study

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaDevice studyAges 18–55
Countries
Sponsor
First Affiliated Hospital of Fujian Medical University
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.